J Clin Med Res

Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access

Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc

Journal website http://www.jocmr.org

Original Article

Volume 11, Number 4, April 2019, pages 256-260

Long-Term Efficacy, Safety, and Tolerability of Modified Intravesical Oxybutynin Chloride for Neurogenic Bladder in Children

Figure

Figure 1. Cystometrograms of patient 1 before and after treatment.

Tables

**Table 1.** Patient Profiles
Patient	Age	Sex	Disease
y: years; m: months.
1	3y7m	Male	Pelvic teratoma
2	1y6m	Male	Myelomeningocele
3	1y6m	Female	Myelomeningocele
4	2y5m	Male	Myelomeningocele

**Table 2.** Bladder Compliance, Detrusor Overactivity and Urinary Incontinence Before and After Treatment
Patient	Bladder compliance (cm H₂O/mL)				Detrusor overactivity				Urinary incontinence
Patient	Before	1 y later	3 y later	10 y later	Before	1 y later	3 y later	10 y later	Before	1 y later	3 y later	10 y later
y: years; m: month; d: day; NP: not performed. ^aat 118 months.
1	1.7	6.7	6.5	3.7^a	+	+	−	+^a	3 times/m	None	None	2.3 times/d^a
2	0.2	3.5	4.7	10.5	+	−	−	−	4.6 times/d	3 times/m	None	None
3	0.1	10.0	9.3	9.7	+	−	−	−	None	None	None	None
4	2.5	NP	5.9	11.8	+	NP	−	−	4.5 times/d	None	None	None

**Table 3.** Incidence of UTIs
Patient	1 y before instituting treatment	1 y after instituting treatment	3 y after instituting treatment	10 y after instituting treatment
UTI: urinary tract infection; ABU: asymptomatic bacteriuria. ^aat 118 months.
1	Lower UTI (3 times)	None	None	Upper UTI (2 times)^a
2	ABU	ABU	None	None
3	ABU	None	None	None
4	ABU	ABU	ABU	ABU